Comparison of pyrantel pamoate and piperazine phosphate in the treatment of ascariasis.
D000284:Administration, Oral; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use*; D001196:Ascariasis / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D001200:Ascaris; D002264:Carboxylic Acids / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D005243:Feces / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D009281:Naphthalenes / Q000627:therapeutic use; D010270:Parasite Egg Count; D010710:Phosphates / Q000008:administration & dosage / Q000627:therapeutic use*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use
D000871:Anthelmintics; D002264:Carboxylic Acids; D009281:Naphthalenes; D010710:Phosphates; D010879:Piperazines; D010919:Placebos; D011743:Pyrimidines; D013876:Thiophenes